Afinitor For Benign Brain Tumor Associated With Tuberous Sclerosis Approved By FDA

Links shared publicly online about this topic.

  • 761
    total visits

Afinitor For Benign Brain Tumor Associated With Tuberous Sclerosis Approved By FDA

medicalnewstoday.com

Afinitor (everolimus) in tablet form, a first line drug for the treatment of adults and children with benign brain tumor associated with tuberous sclerosis has been approved by the Food and Drug A

View full resource at medicalnewstoday.com

Tags: Brain, Brain Tumor, Kidney Cancer Medication, Drug, Children's Health, FDA, Afinitor

  • Share

Most Recently Shared on November 1, 2010 at 1:05 pm By:

mnt_healthnews MNT Health News

Afinitor For Benign Brain Tumor Associated With Tuberous Sclerosis Approved By FDA http://mnt.to/3LTV #healthnews

2 years ago...

Also Shared By:

medical_tweets medical_tweets

MNT Neurology News MNT Neurology News

MNT Pediatrics News MNT Pediatrics News

MNT Genetics News MNT Genetics News


Show More...

Afinitor gains indication for subependymal giant cell astrocytoma associated with tuberous sclerosis - ONA

oncologynurseadvisor.com — “Novartis announced that Afinitor (everolimus tablets), an oral kinase inhibitor, has received accelerated approval for subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated with tuberous sclerosis (TS), in patients who require therapeutic intervention but are not candidates for curative surgical resection.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on November 1, 2010 at 4:50 pm By:

ONAcom OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing

Afinitor gains indication for subependymal giant cell astrocytoma associated with tuberous… http://goo.gl/fb/NcTzL

2 years ago...

Afinitor gains indication for subependymal giant cell astrocytoma associated with tuberous sclerosis - MPR

empr.com — “Novartis announced that Afinitor (everolimus tablets), an oral kinase inhibitor, has received accelerated approval for subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated with tuberous sclerosis (TS), in patients who require therapeutic intervention but are not candidates for curative surgical resection.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on November 1, 2010 at 4:18 pm By:

eMPR MPR Medical Publisher

MPR News: Afinitor gains indication for subependymal giant cell astrocytoma associated with tuberous sclerosis: No... http://bit.ly/dkwTmd

2 years ago...

Advertisement